Evicenter
MarkdownMedical informationP&T meetings
Ficerafusp alfa (BCA101)

First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab

Last updated
135 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of HPV-negative head and neck squamous cell carcinoma

4 evidence topics · 5 sources

Prevalence of HPV-negative or recurrent or metastatic disease

No evidence found.